Appeal No. 94-2894
Application 07/725,222
DECISION ON APPEAL
This is an appeal under 35 U.S.C. § 134 from the final rejection of claims 2, 5
through 7, and 9 through 15, all the claims remaining in the application.
Claims 10, 15, and 7 are illustrative of the subject matter on appeal and read as
follows:
10. A dosage form for transdermally administering a pharmaceutically active agent
which dosage form comprises
a) an impermeable backing,
b) a rate-controlling membrane of polyurethane or ethylene-vinyl acetate of greater
than 20% vinyl acetate and from 0.5 to 10.0 mils thick,
c) a silicone-based or acrylic-based pressure sensitive adhesive on said rate
controlling membrane distal from said backing,
d) a reservoir formed by a and b,
e) an aqueous pharmaceutically acceptable lower alkanol reservoir composition
having a volume fraction of said lower alkanol of from 0.39 to 0.9 calculated based on said
alkanol and water only, and
f) said pharmaceutically active agent.
15. A transdermal drug delivery system comprising
(I) an occlusive, impermeable polymeric backing layer;
(ii) a drug depot on one side thereof;
(iii) a removable, occlusive covering layer over said drug depot; and
(iv) an adhesive means by which said delivery system, absent said
removable covering layer may be affixed to an intended patient;
3
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007